Actinium Pharmaceuticals
ATNM
#9845
Rank
A$67.86 M
Marketcap
A$2.18
Share price
2.11%
Change (1 day)
8.49%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -A$68.35 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$63.19 Million, an increase over its 2023 earnings that were of -A$77.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$68.35 Million8.16%
2024 -A$63.19 Million-18.87%
2023 -A$77.9 Million52.24%
2022 -A$51.17 Million36.61%
2021 -A$37.46 Million11.48%
2020 -A$33.6 Million1.46%
2019 -A$33.12 Million-7.37%
2018 -A$35.75 Million-11.46%
2017 -A$40.38 Million10.67%
2016 -A$36.48 Million15.7%
2015 -A$31.54 Million-14.86%
2014 -A$37.04 Million129.19%
2013 -A$16.16 Million-8.55%
2012 -A$17.67 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.04 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-A$55.8 Million-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.01 B-1,635.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$7.47 M-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA